Kiniksa Pharmaceuticals International, plc - COM CL A (KNSA)

Historical Portfolio Holders from Q2 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q3 2024
128K
Holdings value Q3 2024
$3.19M
Value change Q3 2024
+$1.75M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
2
Number of buys Q3 2024
1
Number of sells Q3 2024
-4
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 128K $3.19M +$1.75M $24.99 2
2024 Q2 66.8K $1.25M -$765M $18.66 5
2024 Q1 38.9M $768M +$97.4M $19.73 153
2023 Q4 34.2M $600M -$23.8M $17.54 142
2023 Q3 34.9M $606M +$53.7M $17.37 136
2023 Q2 31.8M $448M +$8.33M $14.08 126
2023 Q1 31.5M $339M +$13.1M $10.76 129
2022 Q4 29.8M $446M +$8.53M $14.98 123
2022 Q3 29.9M $383M +$7.79M $12.84 104
2022 Q2 29.9M $290M -$6.83M $9.69 91
2022 Q1 30.8M $306M +$11.8M $9.94 94
2021 Q4 29.4M $346M +$3.33M $11.77 101
2021 Q3 29.1M $332M -$3.58M $11.39 97
2021 Q2 28.9M $402M -$18M $13.93 101
2021 Q1 29M $538M -$12.6M $18.51 103
2020 Q4 29.8M $526M +$27.5M $17.67 110
2020 Q3 28.3M $434M +$112M $15.32 101
2020 Q2 21.1M $539M +$102M $25.48 94
2020 Q1 17.7M $274M +$42.3M $15.48 73
2019 Q4 15.1M $167M -$17.6K $11.06 59
2019 Q3 15.5M $132M -$17M $8.51 52
2019 Q2 16.5M $224M +$1.32M $13.54 60
2019 Q1 16.3M $295M +$33.9M $18.06 56
2018 Q4 13.7M $385M -$47.6M $28.09 52
2018 Q3 14.4M $363M -$79.1M $25.50 54
2018 Q2 17.3M $298M +$298M $17.35 41